ATROPOS EVIDENCE
LIVE

Serial Number

97854125

Owner

Atropos Health, Inc.

Attorney

Thomas Y. Yee

First Use Date

Dec 10, 2020

Filing Date

Mar 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ATROPOS EVIDENCE Trademark

Serial Number: 97854125 • Registration: 7868580

ATROPOS EVIDENCE is a trademark filed by Atropos Health, Inc. on March 23, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Atropos Health, Inc. (20 trademarks)

169 Madison Avenue, Unit 2242
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

March 23, 2023

Registration Date

July 15, 2025

First Use Anywhere

December 10, 2020

First Use in Commerce

December 10, 2020

Published for Opposition

January 23, 2024

Goods & Services

Downloadable scientific and medical data via the internet

Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of database information and analyses of database information via telecommunications networks; electronic exchange of health data insights via telecommunication networks for analyses of health data from clinicians, health systems, academic medical centers, and others

Business consulting and management in the field of clinical trials, namely, providing information management services

Providing medical information to healthcare providers and healthcare professionals to help them make informed decisions for patient diagnosis and treatment; providing tools to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industry, namely, providing tools in the nature of health assessment services; providing information and data related to patient data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research; providing on-line medical record analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical record analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions

Providing medical, health, and scientific research information, research data, and research services to assist healthcare providers and healthcare professionals in making informed decisions for patient diagnosis and treatment; providing medical and scientific research information in the field of clinical trials; compiling data for research purposes in the field of medical science and medical consultancy; software as a service (SAAS) services featuring software for providing patients diagnosis and treatments for physicians for use in database management; software as a service (SAAS) services featuring software for collecting, storing, indexing, analyzing, updating, managing, sharing, and reporting clinical trial data to evaluate and determine medical diagnosis and treatments; software as a service (SAAS) services featuring software for searching, organizing and managing data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2025 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 24, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2025 CRFA
ASSIGNED TO LIE
Apr 25, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 3, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 3, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 8, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 8, 2024 CNRT
SOU TEAS EXTENSION RECEIVED
Sep 13, 2024 EEXT
STATEMENT OF USE PROCESSING COMPLETE
Aug 20, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 20, 2024 AITU
USE AMENDMENT FILED
Jun 25, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 25, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2023 CNEA
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 1, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 1, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 1, 2023 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2023 NWOS
NEW APPLICATION ENTERED
Mar 27, 2023 NWAP